Patients who want to know which targeted treatments would best treat their cancer using a “liquid biopsy” approach
Genomic analysis by sequencing 73 genes from a blood sample – a liquid biopsy, in situations:
1. When an invasive biopsy can not be performed, or no tumor tissue remains for the genomic analysis.
2. Management of treatment after development of resistance to targeted treatment.
3. Monitor tumor growth and dynamics in real time.